Literature DB >> 16403676

Lentiviral vectors for use in the central nervous system.

Johan Jakobsson1, Cecilia Lundberg.   

Abstract

Lentiviral vectors have been used extensively as gene transfer tools for the central nervous system throughout the past decade since they transduce most cell types in the brain, resulting in high-level and long-term transgene expression. This review discusses some of the recent progress in this field, including preclinical gene therapy experiments in disease models, development of regulated vectors, and the application of siRNA's using lentiviral vectors. We also describe some of the features that make lentiviral vectors a likely candidate for human gene therapy in the brain.

Entities:  

Mesh:

Year:  2006        PMID: 16403676     DOI: 10.1016/j.ymthe.2005.11.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  36 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

2.  Lentiviral Vector-Mediated p27kip1 Expression Facilitates Recovery After Spinal Cord Injury.

Authors:  Min-Hao Chen; Yong-Hua Liu; Hua Xu; Da-Wei Xu; Cheng-Niu Wang; Yi- Wang; Cheng-Wei Duan; Ying Zhou; Peng Kan; Ai-Guo Shen; You-Hua Wang
Journal:  Mol Neurobiol       Date:  2015-11-02       Impact factor: 5.590

3.  Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.

Authors:  Fumitaka Shimizu; Yasuteru Sano; Kazuyuki Saito; Masa-aki Abe; Toshihiko Maeda; Hiroyo Haruki; Takashi Kanda
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

Review 4.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

5.  Continuous expression of corticotropin-releasing factor in the central nucleus of the amygdala emulates the dysregulation of the stress and reproductive axes.

Authors:  E Keen-Rhinehart; V Michopoulos; D J Toufexis; E I Martin; H Nair; K J Ressler; M Davis; M J Owens; C B Nemeroff; M E Wilson
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

Review 6.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

7.  Gene delivery to the nervous system.

Authors:  Manfred Schubert; Xandra Breakefield; Howard Federoff; Robert M Frederickson; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2008-04       Impact factor: 11.454

Review 8.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

Review 9.  Lentiviral vectors for immune cells targeting.

Authors:  Steven Froelich; April Tai; Pin Wang
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

10.  Visualization and genetic modification of resident brain microglia using lentiviral vectors regulated by microRNA-9.

Authors:  Malin Åkerblom; Rohit Sachdeva; Luis Quintino; Erika Elgstrand Wettergren; Katie Z Chapman; Giuseppe Manfre; Olle Lindvall; Cecilia Lundberg; Johan Jakobsson
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.